AU Stock MarketDetailed Quotes

CU6 Clarity Pharmaceuticals Ltd

Watchlist
  • 4.980
  • -0.220-4.23%
20min DelayMarket Closed Jul 5 16:00 AET
1.55BMarket Cap-52421P/E (Static)

Clarity Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-29.59%65.01M
-29.59%65.01M
--92.34M
--92.34M
-Cash and cash equivalents
-43.59%31.21M
-43.59%31.21M
--55.34M
--55.34M
-Notes receivable
125.55%178.7K
125.55%178.7K
--79.23K
--79.23K
-Other receivables
-1.26%3.89M
-1.26%3.89M
--3.94M
--3.94M
Total current assets
-22.98%76.68M
-22.98%76.68M
--99.55M
--99.55M
Non current assets
-Accumulated depreciation
-77.78%-229.74K
-77.78%-229.74K
---129.23K
---129.23K
Regulatory assets
50.24%10M
50.24%10M
--6.66M
--6.66M
Liabilities
Current liabilities
-accounts payable
-0.11%2.85M
-0.11%2.85M
--2.85M
--2.85M
-Total tax payable
125.55%178.7K
125.55%178.7K
--79.23K
--79.23K
Current liabilities
0.48%7.54M
0.48%7.54M
--7.51M
--7.51M
Non current liabilities
Non current accrued expenses
-20.74%206.14K
-20.74%206.14K
--260.09K
--260.09K
Employee benefits
125.55%178.7K
125.55%178.7K
--79.23K
--79.23K
Preferred securities outside stock equity
12.42%802.61K
12.42%802.61K
--713.93K
--713.93K
Total non current liabilities
1.78%7.72M
1.78%7.72M
--7.59M
--7.59M
Shareholders'equity
Share capital
0.53%132.82M
0.53%132.82M
--132.12M
--132.12M
-common stock
0.53%132.82M
0.53%132.82M
--132.12M
--132.12M
Gains losses not affecting retained earnings
13.74%6.73M
13.74%6.73M
--5.92M
--5.92M
Total equity
-22.97%76.9M
-22.97%76.9M
--99.82M
--99.82M
(FY)Jun 30, 2023(Q4)Jun 30, 2023(FY)Jun 30, 2022(Q4)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -29.59%65.01M-29.59%65.01M--92.34M--92.34M
-Cash and cash equivalents -43.59%31.21M-43.59%31.21M--55.34M--55.34M
-Notes receivable 125.55%178.7K125.55%178.7K--79.23K--79.23K
-Other receivables -1.26%3.89M-1.26%3.89M--3.94M--3.94M
Total current assets -22.98%76.68M-22.98%76.68M--99.55M--99.55M
Non current assets
-Accumulated depreciation -77.78%-229.74K-77.78%-229.74K---129.23K---129.23K
Regulatory assets 50.24%10M50.24%10M--6.66M--6.66M
Liabilities
Current liabilities
-accounts payable -0.11%2.85M-0.11%2.85M--2.85M--2.85M
-Total tax payable 125.55%178.7K125.55%178.7K--79.23K--79.23K
Current liabilities 0.48%7.54M0.48%7.54M--7.51M--7.51M
Non current liabilities
Non current accrued expenses -20.74%206.14K-20.74%206.14K--260.09K--260.09K
Employee benefits 125.55%178.7K125.55%178.7K--79.23K--79.23K
Preferred securities outside stock equity 12.42%802.61K12.42%802.61K--713.93K--713.93K
Total non current liabilities 1.78%7.72M1.78%7.72M--7.59M--7.59M
Shareholders'equity
Share capital 0.53%132.82M0.53%132.82M--132.12M--132.12M
-common stock 0.53%132.82M0.53%132.82M--132.12M--132.12M
Gains losses not affecting retained earnings 13.74%6.73M13.74%6.73M--5.92M--5.92M
Total equity -22.97%76.9M-22.97%76.9M--99.82M--99.82M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
%Chg